In addition, thioredoxin has been considered a promising future target for the treatment of digestive tract irritation, chronic obstructive pulmonary disease, and some allergic diseases such as allergic asthma, AR, food allergy, and contact dermatitis (44). The gene discussed is TXN; the disease is chronic obstructive pulmonary disease.